Our Sponsors 2026
We would like to thank our sponsors for supporting the 42nd Annual Meeting of the German Association for the Study of the Liver (GASL) to evolve.
Your GASL Organising Team
Falk Foundation e.V.
Falk Foundation e.V. offers a platform and organizes symposia for experts in gastroenterology and hepatology. Its resources and digital media provide clinicians, students, and researchers with the latest information on diseases, diagnostic procedures, and treatment options.
Homepage: https://falkfoundation.org/de/
20.000,00€*
Boehringer Ingelheim Pharma GmbH
Boehringer Ingelheim is a global biopharmaceutical company in both human and animal health,
investing heavily in research and development to create breakthrough therapies that address unmet medical needs and improve lives worldwide.
Homepage: https://www.boehringer-ingelheim.com/de
7.000,00€*
AstraZeneca GmbH
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to accelerating the delivery of life-changing medication that create enduring value for patients, society, the planet and our shareholders.
Homepage: https://www.astrazeneca.com/
6.500,00€*
GILEAD Sciences GmbH
At Gilead, we strive to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we deliver innovative therapies that offer new hope to those impacted by disease.
Homepage: https://www.gilead.com/de-de
6.500,00€*
GlaxoSmithKline GmbH & Co. KG
GSK is a global biopharma company with the purpose to unite science, technology and talent to get ahead of disease together. Our R&D focus and use of advanced technologies drive innovation in our core therapeutic areas: Respiratory, Immunology; Oncology and Infectious Diseases.
Homepage: https://de.gsk.com/de-de/
6.500,00€*
Ipsen Pharma GmbH
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our teams in more than 40 countries enable us to bring medicines to patients in more than 100 countries.
Homepage: https://www.ipsen.com/germany/
6.500,00€*
Sirtex Medical Europe GmbH
Sirtex Medical ist ein globales Gesundheitsunternehmen zur Verbesserung der Behandlungsergebnisse bei Krebspatienten. Hauptprodukte sind SIR-Spheres® Y-90-Harzmikrosphären zur Radioembolisation von primären und sekundären Lebertumoren sowie EmboCept® S DSM als Adjuvans bei inoperablen Leber- und Lungentumoren.
Homepage: https://www.sirtex.com
4.450,00€*
Echosens Deutschland GmbH
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health.
FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4 200+ peer-reviewed publications and 180+ international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
Homepage: https://www.echosens.com/de/
1.000,00€*
* all amounts exclude VAT